跳至主要内容
临床试验/NL-OMON51243
NL-OMON51243尚未招募4 期

The efficacy of intermittent versus daily oral iron supplementation in anaemic pregnant women. - FER-IDIP trial (FER Intermittent vs Daily In Pregnancy)

Martini Ziekenhuis0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • - Pregnant women of 18 years and older
  • - Iron deficiency anaemia (defined as: Anaemia (haemoglobin lower than cut-off
  • value) AND mean corpuscular volume (MCV) 70-85 fl OR ferritin <30ug/L) OR mean
  • corpuscular volume (MCV) < 70fl / hemoglobinopathy is ruled out.
  • - Adequate mental health
  • - Good command of the Dutch language
  • - No participation in other research with medication
  • - Informed consent

排除标准

  • - Start of iron supplementation at pregnancy duration > 37 weeks (because of
  • the limited time to achieve an increase in haemoglobin).
  • - History of bariatric surgery, inflammatory bowel disease, coeliac disease or
  • Helicobacter pylori infection (because of malabsorption of iron).
  • - Patients who received blood transfusion or parental iron supplementation
  • during the 3 months prior to screening (because of the effect on the
  • haemoglobin level).
  • - Patients with significant bleeding, blood donation or surgery during
  • pregnancy (because of the effect on the haemoglobin level).
  • - Allergy for iron.
  • - Anaemia of other cause, such as a hemoglobinopathy.

研究者

相似试验